Search results
Hong Kong to launch first breastmilk bank next year to aid 600 infants annually
South China Morning Post· 11 hours agoThe bank will begin operation in 2025 with a target of collecting between 600 and 850 litres per...
HKTDC Kicks Off Third International Healthcare Week
NewMediaWire via Yahoo Finance· 10 hours agoAsia Summit on Global Health and Medical Fair commence today Over 80 healthcare experts discuss forward-looking topics at Asia Summit on Global Health,...
Chinese zoo under fire after dyeing dogs to resemble pandas
NBC News via Yahoo News· 6 days agoHONG KONG — A zoo in China has been accused of trying to deceive visitors with a pair of dogs dyed...
When the water is too warm, coral expel their algae and turn white, an effect called "bleaching"...
The San Francisco Examiner· 2 hours agoWhen the water is too warm, coral expel their algae and turn white, an effect called "bleaching"...
SEHK Growth Companies With High Insider Ownership And Earnings Growth Up To 55%
Simply Wall St. via Yahoo Finance· 4 days agoAmid a backdrop of fluctuating global markets, Hong Kong's Hang Seng Index has recently shown...
Opinion | Death of Hong Kong hepatitis B sufferer a reminder to put patient safety first
South China Morning Post· 2 days agoTang was treated for kidney disease at United Christian Hospital and given a heavy dose of steroids....
Opinion | Sino-US youth exchanges are vital – and Hong Kong has a role to play
South China Morning Post· 2 days agoSecondly, taking a youth-oriented angle to Sino-American dialogue circumvents the more politicised...
HUTCHMED begins trial of combination therapy for pancreatic ductal adenocarcinoma
Clinical Trials Arena via Yahoo Finance· 3 days agoHong Kong-based biopharmaceutical company HUTCHMED has begun a Phase II/III clinical trial of...
She was Hong Kong’s ‘happy fruit’: the life of ‘Fei Fei’, comedian Lydia Sum
South China Morning Post· 7 days agoThe Cantonese-language production surpassed Bruce Lee’s Enter the Dragon to become the top local...
...FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early...
Rome Sentinel· 2 days agoFood and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: LEQEMBI®) subcutaneous autoinjector for weekly maintenance dosing after it was granted Fast Track designation by the FDA ...